Epigenetic Regulation during Fetal Femur Development: DNA Methylation Matters

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  de Andrés, María C ^a,b,c   Kingham, Emmajayne ^a,b   Imagawa, Kei ^a,b,d   Gonzalez, Antonio ^c   Roach, Helmtrud I ^a,b   Wilson, David I ^b   Oreffo, Richard O C ^a,b,e  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c Instituto de Investigación Sanitaria de Santiago de Compostela IDIS   (Spain)

^d TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; COLLAGENASE 3; DNA METHYLTRANSFERASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; OSTEOCALCIN; PROTEIN STRO 1; UNCLASSIFIED DRUG;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BONE CELL; BONE DEVELOPMENT; CARTILAGE CELL; CLINICAL ARTICLE; COL9A1 GENE; CONTROLLED STUDY; CPG ISLAND; DEVELOPMENTAL STAGE; DNA METHYLATION; DNA METHYLTRASFERASE 1 GENE; EMBRYO; EMBRYONIC STEM CELL; EPIGENETICS; EXON; FEMUR; FETUS; FETUS DEVELOPMENT; FOOT LENGTH; GENE; GENE EXPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN FETAL BONE CELL; HUMAN TISSUE; IL1B GENE; IMMUNOHISTOCHEMISTRY; INOS GENE; MMP13 GENE; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN LOCALIZATION; PYROSEQUENCING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; TET1 GENE;

ADULT; BONE MARROW CELLS; CHONDROCYTES; COLLAGEN TYPE IX; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA-BINDING PROTEINS; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; FEMUR; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASE 13; NITRIC OXIDE SYNTHASE TYPE II; OSTEOCALCIN; PROMOTER REGIONS, GENETIC;

EID: 84873818150     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054957     Document Type: Article

References (62)

1. Reik W, Walter J, (2001) Genomic imprinting: parental influence on the genome. Nat Rev Genet 2: 21-32.
2. Robertson KD, (2005) DNA methylation and human disease. Nat Rev Genet 6: 597-610.
3. Reik W, Dean W, Walter J, (2001) Epigenetic reprogramming in mammalian development. Science 293: 1089-1093.
4. Cheng X, (1995) Structure and function of DNA methyltransferases. Annu Rev Biophys Biomol Struct 24: 293-318.
5. Godfrey KM, Lillycrop KA, Burdge GC, Gluckman PD, Hanson MA, (2007) Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease. Pediatr Res 61: 5R-10R.
6. Vickaryous N, Whitelaw E, (2005) The role of early embryonic environment on epigenotype and phenotype. Reprod Fertil Dev 17: 335-340.
7. Bird A, (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21.
8. Jackson-Grusby L, Beard C, Possemato R, Tudor M, Fambrough D, et al. (2001) Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet 27: 31-39.
9. Pfeifer GP, Steigerwald SD, Hansen RS, Gartler SM, Riggs AD, (1990) Polymerase chain reaction-aided genomic sequencing of an X chromosome-linked CpG island: methylation patterns suggest clonal inheritance, CpG site autonomy, and an explanation of activity state stability. Proc Natl Acad Sci U S A 87: 8252-8256.
10. Reik W, Walter J, (2001) Evolution of imprinting mechanisms: the battle of the sexes begins in the zygote. Nat Genet 27: 255-256.
11. Mirmalek-Sani SH, Tare RS, Morgan SM, Roach HI, Wilson DI, et al. (2006) Characterization and multipotentiality of human fetal femur-derived cells: implications for skeletal tissue regeneration. Stem Cells 24: 1042-1053.
12. Imagawa K, de Andres MC, Hashimoto K, Pitt D, Itoi E, et al. (2011) The epigenetic effect of glucosamine and a nuclear factor-kappa B (NF-kB) inhibitor on primary human chondrocytes-implications for osteoarthritis. Biochem Biophys Res Commun 405: 362-367.
13. Hashimoto K, Oreffo RO, Gibson MB, Goldring MB, Roach HI, (2009) DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes. Arthritis Rheum 60: 3303-3313.
14. Roach HI, Yamada N, Cheung KS, Tilley S, Clarke NM, et al. (2005) Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum 52: 3110-3124.
15. da Silva MA, Yamada N, Clarke NM, Roach HI, (2009) Cellular and epigenetic features of a young healthy and a young osteoarthritic cartilage compared with aged control and OA cartilage. J Orthop Res 27: 593-601.
16. Stewart K, Monk P, Walsh S, Jefferiss CM, Letchford J, et al. (2003) STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: a comparative investigation in vitro. Cell Tissue Res 313: 281-290.
17. Gronthos S, Graves SE, Ohta S, Simmons PJ, (1994) The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood 84: 4164-4173.
18. Stewart K, Walsh S, Screen J, Jefferiss CM, Chainey J, et al. (1999) Further characterization of cells expressing STRO-1 in cultures of adult human bone marrow stromal cells. J Bone Miner Res 14: 1345-1356.
19. Hashimoto K, Kokubun S, Itoi E, Roach HI, (2007) Improved quantification of DNA methylation using methylation-sensitive restriction enzymes and real-time PCR. Epigenetics 2: 86-91.
20. Chartrain NA, Geller DA, Koty PP, Sitrin NF, Nussler AK, et al. (1994) Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem 269: 6765-6772.
21. Palmer RM, Hickery MS, Charles IG, Moncada S, Bayliss MT, (1993) Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun 193: 398-405.
22. Zhang P, Jimenez SA, Stokes DG, (2003) Regulation of human COL9A1 gene expression. Activation of the proximal promoter region by SOX9. J Biol Chem 278: 117-123.
23. Tardif G, Pelletier JP, Dupuis M, Hambor JE, Martel-Pelletier J, (1997) Cloning, sequencing and characterization of the 5′-flanking region of the human collagenase-3 gene. Biochem J 323 (Pt 1): 13-16.
24. Clark BD, Collins KL, Gandy MS, Webb AC, Auron PE, (1986) Genomic sequence for human prointerleukin 1 beta: possible evolution from a reverse transcribed prointerleukin 1 alpha gene. Nucleic Acids Res 14: 7897-7914.
25. Kerner SA, Scott RA, Pike JW, (1989) Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3. Proc Natl Acad Sci U S A 86: 4455-4459.
26. Dolinoy DC, Weidman JR, Jirtle RL, (2007) Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod Toxicol 23: 297-307.
27. Szyf M, (2011) The early life social environment and DNA methylation: DNA methylation mediating the long-term impact of social environments early in life. Epigenetics 6: 971-978.
28. Montjovent MO, Burri N, Mark S, Federici E, Scaletta C, et al. (2004) Fetal bone cells for tissue engineering. Bone 35: 1323-1333.
29. Krattinger N, Applegate LA, Biver E, Pioletti DP, Caverzasio J, (2011) Regulation of proliferation and differentiation of human fetal bone cells. Eur Cell Mater 21: 46-58.
30. Zaragoza C, Lopez-Rivera E, Garcia-Rama C, Saura M, Martinez-Ruiz A, et al. (2006) Cbfa-1 mediates nitric oxide regulation of MMP-13 in osteoblasts. J Cell Sci 119: 1896-1902.
31. Corbett SA, Hukkanen M, Batten J, McCarthy ID, Polak JM, et al. (1999) Nitric oxide in fracture repair. Differential localisation, expression and activity of nitric oxide synthases. J Bone Joint Surg Br 81: 531-537.
32. Diwan AD, Wang MX, Jang D, Zhu W, Murrell GA, (2000) Nitric oxide modulates fracture healing. J Bone Miner Res 15: 342-351.
33. Wang FS, Kuo YR, Wang CJ, Yang KD, Chang PR, et al. (2004) Nitric oxide mediates ultrasound-induced hypoxia-inducible factor-1alpha activation and vascular endothelial growth factor-A expression in human osteoblasts. Bone 35: 114-123.
34. Zhu W, Diwan AD, Lin JH, Murrell GA, (2001) Nitric oxide synthase isoforms during fracture healing. J Bone Miner Res 16: 535-540.
35. Aguirre J, Buttery L, O'Shaughnessy M, Afzal F, Fernandez de Marticorena I, et al. (2001) Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity. Am J Pathol 158: 247-257.
36. Armour KE, Armour KJ, Gallagher ME, Godecke A, Helfrich MH, et al. (2001) Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. Endocrinology 142: 760-766.
37. Collin-Osdoby P, Nickols GA, Osdoby P, (1995) Bone cell function, regulation, and communication: a role for nitric oxide. J Cell Biochem 57: 399-408.
38. Turner CH, Owan I, Jacob DS, McClintock R, Peacock M, (1997) Effects of nitric oxide synthase inhibitors on bone formation in rats. Bone 21: 487-490.
39. van't Hof RJ, Ralston SH, (2001) Nitric oxide and bone. Immunology 103: 255-261.
40. Cuzzocrea S, Mazzon E, Dugo L, Genovese T, Di Paola R, et al. (2003) Inducible nitric oxide synthase mediates bone loss in ovariectomized mice. Endocrinology 144: 1098-1107.
41. Wang FS, Wang CJ, Chen YJ, Huang YT, Huang HC, et al. (2004) Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats. Endocrinology 145: 2148-2156.
42. Sengupta PK, Smith BD, (1998) Methylation in the initiation region of the first exon suppresses collagen pro-alpha2(I) gene transcription. Biochim Biophys Acta 1443: 75-89.
43. Levine A, Cantoni GL, Razin A, (1992) Methylation in the preinitiation domain suppresses gene transcription by an indirect mechanism. Proc Natl Acad Sci U S A 89: 10119-10123.
44. Weber M, Schubeler D, (2007) Genomic patterns of DNA methylation: targets and function of an epigenetic mark. Curr Opin Cell Biol 19: 273-280.
45. Delgado-Calle J, Sanudo C, Bolado A, Fernandez AF, Arozamena J, et al. (2012) DNA methylation contributes to the regulation of sclerostin expression in human osteocytes. J Bone Miner Res 27: 926-937.
46. Hagg R, Hedbom E, Mollers U, Aszodi A, Fassler R, et al. (1997) Absence of the alpha1(IX) chain leads to a functional knock-out of the entire collagen IX protein in mice. J Biol Chem 272: 20650-20654.
47. Fassler R, Schnegelsberg PN, Dausman J, Shinya T, Muragaki Y, et al. (1994) Mice lacking alpha 1 (IX) collagen develop noninflammatory degenerative joint disease. Proc Natl Acad Sci U S A 91: 5070-5074.
48. Dreier R, Opolka A, Grifka J, Bruckner P, Grassel S, (2008) Collagen IX-deficiency seriously compromises growth cartilage development in mice. Matrix Biol 27: 319-329.
49. Alizadeh BZ, Njajou OT, Bijkerk C, Meulenbelt I, Wildt SC, et al. (2005) Evidence for a role of the genomic region of the gene encoding for the alpha1 chain of type IX collagen (COL9A1) in hip osteoarthritis: A population-based study. Arthritis Rheum 52: 1437-1442.
50. Kriaucionis S, Heintz N, (2009) The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324: 929-930.
51. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, et al. (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324: 930-935.
52. Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, et al. (2010) Role of Tet proteins in 5 mC to 5 hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466: 1129-1133.
53. Valinluck V, Sowers LC, (2007) Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res 67: 946-950.
54. Ficz G, Branco MR, Seisenberger S, Santos F, Krueger F, et al. (2011) Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473: 398-402.
55. Brown JP, Delmas PD, Malaval L, Edouard C, Chapuy MC, et al. (1984) Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1: 1091-1093.
56. Arnsdorf EJ, Tummala P, Castillo AB, Zhang F, Jacobs CR, (2010) The epigenetic mechanism of mechanically induced osteogenic differentiation. J Biomech 43: 2881-2886.
57. Villagra A, Gutierrez J, Paredes R, Sierra J, Puchi M, et al. (2002) Reduced CpG methylation is associated with transcriptional activation of the bone-specific rat osteocalcin gene in osteoblasts. J Cell Biochem 85: 112-122.
58. Kitazawa R, Kitazawa S, (2007) Methylation status of a single CpG locus 3 bases upstream of TATA-box of receptor activator of nuclear factor-kappaB ligand (RANKL) gene promoter modulates cell- and tissue-specific RANKL expression and osteoclastogenesis. Mol Endocrinol 21: 148-158.
59. Lu TY, Kao CF, Lin CT, Huang DY, Chiu CY, et al. (2009) DNA methylation and histone modification regulate silencing of OPG during tumor progression. J Cell Biochem 108: 315-325.
60. El-Serafi AT, Oreffo RO, Roach HI, (2011) Epigenetic modifiers influence lineage commitment of human bone marrow stromal cells: Differential effects of 5-aza-deoxycytidine and trichostatin A. Differentiation. 81: 35-41.
61. Delgado-Calle J, Sanudo C, Sanchez-Verde L, Garcia-Renedo RJ, Arozamena J, et al. (2011) Epigenetic regulation of alkaline phosphatase in human cells of the osteoblastic lineage. Bone 49: 830-838.
62. Lanham SA, Bertram C, Cooper C, Oreffo RO (2011) Animal models of maternal nutrition and altered offspring bone structure-bone development across the lifecourse. Eur Cell Mater 22: 321-332; discussion 332.